Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig A Erickson

Showing results (1-10 of 157) with videos related to

Pageof 16
Sort By:
Current Problems in Pediatric and Adolescent Health Care|September 29, 2018
Pharmacological management of behavioral disturbances in children and adolescents with autism spectrum disordersMartine Lamy, Craig A Erickson
Expert Opinion on Investigational Drugs|July 30, 2019
Investigational drugs in early-stage clinical trials for autism spectrum disorderMichael P Hong, Craig A Erickson
The Journal of Clinical Psychiatry|July 20, 2006
Memantine for disruptive behavior in autistic disorderCraig A Erickson, Joanna E Chambers
Pediatric Clinics of North America|October 21, 2024
Innovative Approaches to Addressing Pediatric Mental HealthRobert T Ammerman, Craig A Erickson
The Application of Clinical Genetics|April 22, 2015
Emerging pharmacologic treatment options for fragile X syndromeTori L Schaefer, Matthew H Davenport, Craig A Erickson
Journal of Neurodevelopmental Disorders|May 4, 2020
Developmental studies in fragile X syndromeKhaleel A Razak, Kelli C Dominick, Craig A Erickson
Current Treatment Options in Neurology|September 18, 2010
Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disordersLogan K Wink, Craig A Erickson, Christopher J McDougle
Journal of Autism and Developmental Disorders|July 18, 2009
Open-label memantine in fragile X syndromeCraig A Erickson, Jennifer E Mullett, Christopher J McDougle
Journal of Autism and Developmental Disorders|March 10, 2010
Brief report: acamprosate in fragile X syndromeCraig A Erickson, Jennifer E Mullett, Christopher J McDougle
Handbook of Clinical Neurology|November 16, 2019
Psychopharmacology of neurobehavioral disordersLindsey N Mooney, Kelli C Dominick, Craig A Erickson
Pageof 16

Showing results (1-10 of 157) with videos related to

Sort By:
Pageof 16
Current Problems in Pediatric and Adolescent Health Care|September 29, 2018
Pharmacological management of behavioral disturbances in children and adolescents with autism spectrum disordersMartine Lamy, Craig A Erickson
Expert Opinion on Investigational Drugs|July 30, 2019
Investigational drugs in early-stage clinical trials for autism spectrum disorderMichael P Hong, Craig A Erickson
The Journal of Clinical Psychiatry|July 20, 2006
Memantine for disruptive behavior in autistic disorderCraig A Erickson, Joanna E Chambers
Pediatric Clinics of North America|October 21, 2024
Innovative Approaches to Addressing Pediatric Mental HealthRobert T Ammerman, Craig A Erickson
The Application of Clinical Genetics|April 22, 2015
Emerging pharmacologic treatment options for fragile X syndromeTori L Schaefer, Matthew H Davenport, Craig A Erickson
Journal of Neurodevelopmental Disorders|May 4, 2020
Developmental studies in fragile X syndromeKhaleel A Razak, Kelli C Dominick, Craig A Erickson
Current Treatment Options in Neurology|September 18, 2010
Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disordersLogan K Wink, Craig A Erickson, Christopher J McDougle
Journal of Autism and Developmental Disorders|July 18, 2009
Open-label memantine in fragile X syndromeCraig A Erickson, Jennifer E Mullett, Christopher J McDougle
Journal of Autism and Developmental Disorders|March 10, 2010
Brief report: acamprosate in fragile X syndromeCraig A Erickson, Jennifer E Mullett, Christopher J McDougle
Handbook of Clinical Neurology|November 16, 2019
Psychopharmacology of neurobehavioral disordersLindsey N Mooney, Kelli C Dominick, Craig A Erickson
Pageof 16